Andrea Johnson
Psychiatric/Mental Health · Waverly, IANPI 1477142289
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.2% of the total across 659 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 659 payments — averaging $12.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$1K
- Alkermes, Inc.$963
- Otsuka America Pharmaceutical, Inc.$884
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$789
- Johnson & Johnson$739
- Teva Pharmaceuticals USA, Inc.$624
- plus $3K from 13 others
What the payments were for
- Food & beverage$7,92197%
- Education$2303%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 198 | $1,335 |
| Alkermes, Inc. | 62 | $963 |
| Otsuka America Pharmaceutical, Inc. | 68 | $884 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 43 | $789 |
| Johnson & Johnson | 58 | $739 |
| Teva Pharmaceuticals USA, Inc. | 32 | $624 |
| Lundbeck LLC | 28 | $451 |
| AbbVie | 44 | $402 |
| Sunovion Pharmaceuticals Inc. | 17 | $338 |
| Supernus Pharmaceuticals, Inc. | 21 | $307 |
| Vanda Pharmaceuticals Inc. | 18 | $269 |
| Corium, LLC | 21 | $246 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $178 |
| E.r. Squibb & Sons, L.L.C. | 11 | $175 |
| Axsome Therapeutics, Inc. | 9 | $157 |
| Ironshore Pharmaceuticals Inc. | 10 | $156 |
| Almatica Pharma LLC | 5 | $80 |
| Collegium Pharmaceutical, Inc. | 2 | $34 |
| Idorsia Pharmaceuticals US Inc | 1 | $24 |
How this compares
$8,150 in reported general payments places this provider in the 95th percentile of 443 psychiatric/mental health providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 65 | $506,624 |
| Invega SustennaPaliperidone Palmitate | 110 | $319,250 |
| VraylarCariprazine Hcl | 103 | $143,726 |
| Abilify MaintenaAripiprazole | 51 | $134,331 |
| RexultiBrexpiprazole | 55 | $82,988 |
| LybalviOlanzapine/Samidorphan Malate | 35 | $55,072 |
| Risperdal ConstaRisperidone Microspheres | 40 | $49,288 |
| CaplytaLumateperone Tosylate | 24 | $39,599 |
| Loreev XrLorazepam | 62 | $27,388 |
| QuviviqDaridorexant Hcl | 41 | $20,396 |
| Paliperidone ErPaliperidone | 115 | $18,077 |
| TrintellixVortioxetine Hydrobromide | 36 | $15,880 |
| AuvelityDextromethorphan Hbr/Bupropion | 15 | $13,296 |
| Clozapine | 51 | $4,894 |
| Aripiprazole | 101 | $4,611 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $1,335 | $506,62465 claims |
| Johnson & JohnsonInvega Sustenna, Risperdal Consta | $739 | $368,538150 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $884 | $217,319106 claims |
| AbbVieVraylar | $402 | $143,726103 claims |
| Alkermes, Inc.Lybalvi | $963 | $55,07235 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $789 | $39,59924 claims |
| Almatica Pharma LLCLoreev Xr | $80 | $27,38862 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $24 | $20,39641 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $178 | $15,88036 claims |
| Axsome Therapeutics, Inc.Auvelity | $157 | $13,29615 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 443 psychiatric/mental health providers in Iowa.
Other psychiatric/mental health in Waverly
- Lacie TheisWaverly$9K
- Tarrah HollidayAtlantic$421K
- Kelsie SwisherParkersburg$235K
- Jennifer BradleyCedar Rapids$66K
- Kama AusbornWaterloo$64K
- Quentin ChambersDes Moines$40K
- Tenaea JeppesonFort Dodge$38K
- Jennifer WittmanCoralville$25K
- Amy MorinCedar Rapids$24K
- Jenna BerendzenCedar Falls$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.